Biobehavioral Effects of Qigong During Treatment for Rectal Cancer

气功治疗直肠癌的生物行为效应

基本信息

  • 批准号:
    7591776
  • 负责人:
  • 金额:
    $ 21.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-04-01 至 2011-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cancer and its treatment are associated with considerable distress, impaired quality of life, poor mental health, and reduced physical function. This is particularly true for patients with rectal cancer who receive multimodal treatment over an extended period of time. Most patients will undergo radiotherapy, followed by surgery and often chemotherapy. It is important to develop programs that can help ameliorate the treatment-related morbidity that accumulates over time for patients with rectal cancer. Furthermore, given the stressful time demands of undergoing radiotherapy (patients typically receive treatment 5 days per week for 6 weeks) it is crucial that programs be easily incorporated into the treatment schedule. Research suggests that stress- reduction programs tailored to the cancer setting help patients cope with the acute effects of treatment and improve QOL after treatment. Qigong, an ancient practice for manipulating one's own Qi (energy flow) to benefit one's physical, emotional, mental, or spiritual health incorporates stress-reduction techniques including regulated breathing, visual imagery, meditation, and various gentle movements. Qigong may be particularly useful for patients with rectal cancer while undergoing radiation treatment and prior to surgery and chemotherapy because of the stress management and relaxation techniques and the gentle movements that should facilitate recovery. In this feasibility/pilot project, we will pilot-test and examine the feasibility and usefulness of conducting a Qigong program with rectal cancer patients as an adjuvant to their radiotherapy treatment. Rectal cancer patients undergoing radiotherapy treatment will be randomly assigned Patients with rectal cancer who are undergoing chemo-radiotherapy will be randomly assigned to either a Qigong group (QI), or a light exercise control group (LE), or a waitlist control group (WL). Participants in the QI and LE groups will attend sessions 3 days/week throughout their 6-week radiotherapy schedule. The sessions will be coordinated with the treatment schedule and conducted adjacent to the treatment facility. Measures will be obtained prior to randomization, a brief assessment in the middle of radiotherapy, during last week of radiotherapy, and 1 and 3 months after the end of radiotherapy. In addition to determining the acceptability and feasibility of the program, this study will also examine the effects of the Qigong program on fatigue and sleep disturbances. Secondary indices of adjustment include QOL and mental health. We hypothesize that the Qigong program will be feasible and that patients will find the program acceptable and a positive experience. Integrating a Qigong program into the treatment regimen for patients undergoing radiotherapy will make it relatively easy to participate in the program and we hypothesize that such a program will help facilitate recovery and alleviate the psychological and physiological side effects experienced by patients who are currently undergoing radiotherapy. Public Health Relevance Paragraph: The proposed study will examine the feasibility and initial usefulness of incorporating a Qigong program alongside radiotherapy for patients with rectal cancer. If we find that the Qigong program facilitates recovery and alleviates the psychological and physiological side effects experienced by patients undergoing radiotherapy then this type of program can be incorporated into the treatment plan. As the proposed trial is a feasibility/pilot project a larger trial would need to be conducted and possibly include other cancer populations undergoing radiotherapy.
描述(由申请人提供):癌症及其治疗与相当大的困扰,生活质量受损,精神健康不良和身体机能减少有关。对于长时间接受多模式治疗的直肠癌患者尤其如此。大多数患者将接受放疗,然后进行手术和通常化疗。重要的是要开发可以帮助改善与治疗相关的发病率的计划,从而为直肠癌患者累积了随着时间的流逝而积累。此外,鉴于接受放射治疗的压力时间(通常每周5天治疗6周)的压力时间很高,因此很容易将程序纳入治疗时间表至关重要。研究表明,量身定制的针对癌症设置的压力减轻计划有助于患者应对治疗的急性影响并改善治疗后的QOL。气功,一种古老的做法,用于操纵自己的气(能量流),以使自己的身体,情感,心理或精神健康受益,其中包括减轻压力的技术,包括受调节的呼吸,视觉图像,冥想和各种温和运动。气功可能对直肠癌患者特别有用,同时接受放射治疗,并且在手术和化学疗法之前进行了压力管理和放松技术以及应促进康复的轻柔运动。在这个可行性/试点项目中,我们将进行试点测试并检查与直肠癌患者进行气功计划的可行性和实用性,作为其放射治疗的辅助药物。接受放疗治疗的直肠癌患者将是随机分配的直肠癌患者,他们正在接受化学疗法的患者将随机分配给气功组(QI)或轻运动对照组(LE)或侍应列表控制组(WL)。 QI和LE小组的参与者将在6周的放射疗法计划中参加3天/周的课程。课程将与治疗时间表协调,并在治疗设施附近进行。在放射疗法的最后一周,放射疗法的最后一周以及放疗结束后的1和3个月,将在随机分组之前获得措施。除了确定程序的可接受性和可行性外,本研究还将检查气功计划对疲劳和睡眠障碍的影响。调整的次要指标包括QOL和心理健康。我们假设气功计划将是可行的,并且患者会发现该计划可以接受和积极的经验。将气功计划整合到接受放射疗法的患者的治疗方案中,将使参与该计划相对容易,我们假设这样的计划将有助于促进康复并减轻目前正在放射治疗的患者所经历的心理和生理副作用。 公共卫生相关性段落:拟议的研究将检查将气功计划与放射疗法同时纳入直肠癌患者的可行性和最初有用性。如果我们发现气功计划有助于康复并减轻接受放射治疗的患者所经历的心理和生理副作用,那么可以将这种类型的程序纳入治疗计划中。由于拟议的试验是一个可行性/试验项目,需要进行更大的试验,并可能包括接受放疗的其他癌症种群。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Lorenzo Cohen的其他基金

Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
乳腺癌手术期间护士催眠的阿片类药物节省效果
  • 批准号:
    10668632
    10668632
  • 财政年份:
    2023
  • 资助金额:
    $ 21.89万
    $ 21.89万
  • 项目类别:
Personalized Integrative Oncology: Targeted Approaches for Optimal Outcomes
个性化综合肿瘤学:实现最佳结果的针对性方法
  • 批准号:
    8838465
    8838465
  • 财政年份:
    2014
  • 资助金额:
    $ 21.89万
    $ 21.89万
  • 项目类别:
Community-Based, Phase III Trial of acupuncture to treat chronic Xerostomia
针灸治疗慢性口干症的社区 III 期试验
  • 批准号:
    8458083
    8458083
  • 财政年份:
    2012
  • 资助金额:
    $ 21.89万
    $ 21.89万
  • 项目类别:
Community-Based, Phase III Trial of acupuncture to treat chronic Xerostomia
针灸治疗慢性口干症的社区 III 期试验
  • 批准号:
    8643775
    8643775
  • 财政年份:
    2012
  • 资助金额:
    $ 21.89万
    $ 21.89万
  • 项目类别:
Community-Based, Phase III Trial of acupuncture to treat chronic Xerostomia
针灸治疗慢性口干症的社区 III 期试验
  • 批准号:
    8296964
    8296964
  • 财政年份:
    2012
  • 资助金额:
    $ 21.89万
    $ 21.89万
  • 项目类别:
Placebo Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia
针灸预防辐射引起的口干症的安慰剂对照试验
  • 批准号:
    8230482
    8230482
  • 财政年份:
    2011
  • 资助金额:
    $ 21.89万
    $ 21.89万
  • 项目类别:
Placebo Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia
针灸预防辐射引起的口干症的安慰剂对照试验
  • 批准号:
    8444600
    8444600
  • 财政年份:
    2011
  • 资助金额:
    $ 21.89万
    $ 21.89万
  • 项目类别:
Placebo Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia
针灸预防辐射引起的口干症的安慰剂对照试验
  • 批准号:
    8607153
    8607153
  • 财政年份:
    2011
  • 资助金额:
    $ 21.89万
    $ 21.89万
  • 项目类别:
Placebo Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia
针灸预防辐射引起的口干症的安慰剂对照试验
  • 批准号:
    8043902
    8043902
  • 财政年份:
    2011
  • 资助金额:
    $ 21.89万
    $ 21.89万
  • 项目类别:
Yoga for women with breast cancer undergoing radiotherapy
适合接受放射治疗的乳腺癌女性的瑜伽
  • 批准号:
    8041091
    8041091
  • 财政年份:
    2010
  • 资助金额:
    $ 21.89万
    $ 21.89万
  • 项目类别:

相似国自然基金

穿透性靶向胰腺癌内cDC1的纳米佐剂调控溶酶体逃逸促进放疗诱导ICD的机制研究
  • 批准号:
    82303680
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
多级改造的工程化外泌体自佐剂疫苗平台实现鼻上皮细胞感染拟态和粘膜递送的研究
  • 批准号:
    32371440
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
展示PD-L1抗体的纳米锰佐剂联合放疗以诱导原位肿瘤疫苗的产生及其机制的探究
  • 批准号:
    32371518
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
靶向FPPS的双磷酸疫苗佐剂的开发
  • 批准号:
    82341040
  • 批准年份:
    2023
  • 资助金额:
    100 万元
  • 项目类别:
    专项基金项目
应用于冠状病毒广谱疫苗开发的新型全链式免疫增强型佐剂研究
  • 批准号:
    82341036
  • 批准年份:
    2023
  • 资助金额:
    110 万元
  • 项目类别:
    专项基金项目

相似海外基金

Enhancing TET activity for the treatment of hematological malignancy
增强 TET 活性治疗血液恶性肿瘤
  • 批准号:
    10717715
    10717715
  • 财政年份:
    2023
  • 资助金额:
    $ 21.89万
    $ 21.89万
  • 项目类别:
Effects of Exercise on Changes in Cardiovascular Biomarkers in Patients with Breast Cancer During Anthracycline-based Chemotherapy
运动对蒽环类化疗期间乳腺癌患者心血管生物标志物变化的影响
  • 批准号:
    10579380
    10579380
  • 财政年份:
    2023
  • 资助金额:
    $ 21.89万
    $ 21.89万
  • 项目类别:
Targeting T2 inflammation-evoked mechanical endotypes of ASM shortening in asthma
靶向哮喘中 ASM 缩短的 T2 炎症诱发机械内型
  • 批准号:
    10657988
    10657988
  • 财政年份:
    2023
  • 资助金额:
    $ 21.89万
    $ 21.89万
  • 项目类别:
Development of LPA5 Antagonists as Analgesics
LPA5 拮抗剂镇痛药的开发
  • 批准号:
    10638278
    10638278
  • 财政年份:
    2023
  • 资助金额:
    $ 21.89万
    $ 21.89万
  • 项目类别:
Non-inferiority trial of a therapeutic vaccine against Chagas disease in naturally-infected rhesus macaques
在自然感染的恒河猴中进行恰加斯病治疗性疫苗的非劣效性试验
  • 批准号:
    10561401
    10561401
  • 财政年份:
    2023
  • 资助金额:
    $ 21.89万
    $ 21.89万
  • 项目类别: